Dimethylclonidin | 52398-24-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Dimethylclonidin
• 英文别名: 2-<(N-(2,6-Dichlorphenyl)-N-methylamino>-1-methyl-2-imidazolin；(2,6-dichloro-phenyl)-methyl-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)-amine；N-(2,6-Dichlorophenyl)-N,1-dimethyl-4,5-dihydro-1H-imidazol-2-amine；N-(2,6-dichlorophenyl)-N,1-dimethyl-4,5-dihydroimidazol-2-amine
• CAS: 52398-24-0
• 化学式: C₁₁H₁₃Cl₂N₃
• 分子量: 258.15
• InChiKey: HUHRYAAKXTYUMZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  18.8
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOARTICULAR DISEASES
  申请人：Bone Therapeutics

  公开号：EP2257289B1

  公开（公告）日：2018-09-19
• COMPOSITIONS COMPRISING SOLVENT/DETERGENT-TREATED PLASMA AND HYALURONIC ACID FOR USE IN THE TREATMENT OF MUSKULOSKELETAL DISORDERS
  申请人：Bone Therapeutics S.A.

  公开号：EP2900247B1

  公开（公告）日：2018-01-17
• A COMPOSITION, A KIT AND USE THEREOF
  申请人：TheraVet SA

  公开号：EP3996722A1

  公开（公告）日：2022-05-18
• A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITION
  申请人：TheraVet SA

  公开号：EP3996673A1

  公开（公告）日：2022-05-18
• PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES
  申请人：Bastianelli Enrico

  公开号：US20100285134A1

  公开（公告）日：2010-11-11

  An intra-articular pharmaceutical composition is used for the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis. The composition includes a possibly adequate pharmaceutical carrier or diluent, a glycosaminoglycan, a compound activating the alpha 2 adrenergic receptor, an anti-inflammatory agent and stem cells.